Phio Pharmaceuticals Corp.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Assets
Cash & Equivalents $3.6M $12.9M $5.1M $8.5M $11.4M $5.1M $503.0K
Accounts Receivable — — — — — — —
Inventory — — — — — — —
Total Current Assets $3.8M $13.1M $11.0M $9.0M $14.7M $5.4M $1.3M
Property, Plant & Equipment $248.0K $114.0K $163.0K $183.0K $177.0K $198.0K $355.0K
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $4.1M $13.4M $11.2M $9.2M $14.9M $5.6M $1.7M
Liabilities
Accounts Payable $511.0K $917.0K $1.2M $285.0K $163.0K $416.0K $387.0K
Total Current Liabilities $2.3M $2.5M $2.3M $1.3M $2.1M $1.7M $1.8M
Long-Term Debt — — — — — — —
Total Liabilities $2.3M $2.5M $2.3M $6.4M $2.1M $1.7M $2.3M
Stockholders' Equity
Retained Earnings $-78.6M $-66.1M $-57.1M $-46.9M $-38.1M $17.2M —
Total Stockholders' Equity $1.8M $10.9M $8.9M $2.7M $4.9M $-5.8M $-587.0K
← Newer Page 2 of 2 Older →